Icahn School of Medicine at Mount Sinai
- Myeloid Malignancy Workshop
- Challenges in Internal Medicine
- IBD Course for Ukraine
- The Friedman Brain Institute
- Advances in Peritoneal Dialysis Annual Symposium
- Dr. Shanna Swan
- Videos
- Events
- The Dialysis Odyssey
- Pediatric Endocrinology
- 1st Annual Mount Sinai MASLD/MASH (NAFLD/NASH) Center of Excellence Symposium
Playback speed
10 seconds
Developing KCNQ Channel Openers as Novel Antidepressants: Rationale for Targeting the KCNQ2/3 Channels for Depression & Anhedonia
By
Icahn School of Medicine at Mount Sinai
FEATURING
James W. Murrough
By
Icahn School of Medicine at Mount Sinai
FEATURING
James W. Murrough
8 views
May 18, 2021
Comments 0
Login to view comments.
Click here to Login
The Friedman Brain Institute